Patents by Inventor Gilbert Faure

Gilbert Faure has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic TREM-1 peptides
    Patent number: 10603357
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: March 31, 2020
    Assignees: Bristol-Myers Squibb Company, Universite de Lorraine
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Therapeutic TREM-1 peptides
    Patent number: 9273111
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: March 1, 2016
    Assignees: Universite de Lorraine, Bristol-Myers Squibb
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Method of diagnosing infectious disease by measuring the level of soluble TREM-1 in a sample
    Patent number: 8021836
    Abstract: The present invention concerns a method of diagnosing disease of bacterial or fungal origin in a subject, which method comprises the step of measuring the level of Strem-1 in a biological sample obtained from said subject.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: September 20, 2011
    Assignee: Université Henri Poincaré-Nancy I
    Inventors: Marie Nathalie Kolopp-Sarda, Marie-Christine Bene, Paola Panina, Pietro Di Lucia, Bruno Levy, Pierre-Edouard Bollaert, Gilbert Faure, Sebastien Gibot
  • Therapeutic peptides and method
    Patent number: 8013116
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: September 6, 2011
    Assignees: Universite Henri-Poincare-Nancy I, Novo Nordisk A/S
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Therapeutic peptides and method
    Publication number: 20090253632
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Application
    Filed: February 2, 2009
    Publication date: October 8, 2009
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Method Of Diagnosing Infectious Disease By Measuring The Level Of Soluble Trem-1 In A Sample
    Publication number: 20070281319
    Abstract: The present invention concerns a method of diagnosing disease of bacterial or fungal origin in a subject, which method comprises the step of measuring the level of Strem-1 in a biological sample obtained from said subject.
    Type: Application
    Filed: January 27, 2005
    Publication date: December 6, 2007
    Inventors: Marie Kolopp-Sarda, Marie-Christine Bene, Paola Panina, Pietro Di Lucia, Bruno Levy, Pierre-Edouard Bollaert, Gilbert Faure, Sebastien Gibot
  • Therapeutic peptides and method
    Publication number: 20060246082
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of sepsis, septic shock or sepsis-like conditions.
    Type: Application
    Filed: November 22, 2005
    Publication date: November 2, 2006
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Antigenic peptides reacting with anti-ovary antibodies
    Publication number: 20050260200
    Abstract: An oligopeptides comprising the following sequence Thr Gln Cys His Cys Gly Lys Cys (SEQ ID NO: 5) may be used as an antigenic compound capable of being recognized by anti-ovary antibodies and as an immunogenic compound capable of inducing the production of anti-ovary antibodies. In addition, the oligopeptides may be used to detect and/or quantify anti-ovary antibodies.
    Type: Application
    Filed: June 2, 2005
    Publication date: November 24, 2005
    Applicant: BIO MERIEUX
    Inventors: Colette Jolivet-Reynaud, Gilbert Faure, Pascal Dalbon, Michel Jolivet, Marie-Christine Bene
  • Antigenic peptides reacting with anti-ovary antibodies
    Patent number: 6602853
    Abstract: Oligopeptides containing one of SEQ ID NOs: 1-5 may be used as antigenic compounds to recognize anti-ovary antibodies. The oligopeptides may also be used as immunogenic compounds to induce the production of anti-ovary antibodies.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: August 5, 2003
    Assignee: Bio Merieux
    Inventors: Colette Jolivet-Reynaud, Gilbert Faure, Pascal Dalbon, Michel Jolivet, Marie-Christine Bene